BioSpace News Archive

Cardiac troponin I (cTnI) concentrations measured with the Singulex ultrasensitive cTnI assay, powered by Single Molecule Counting technology, were associated with a higher prevalence of coronary artery disease (CAD) and independently predicted cardiovascular events in patients with obstructive and non-obstructive CAD, according to a study published in the Journal of the American Heart Association.

Arrevus Inc., a biotechnology company developing chaperone protein inhibitors to combat antimicrobial resistance, announced the addition of three new board members: Barry Garfinkle, Joe McMahon, and Joe St. Geme.

Unprecedented Clinical Data Could Capture $3B Uncontested Market

(A Non-Randomized Study Evaluating the Use of the Reflow Medical Wingman Catheter to Cross Chronic Total Occlusions in Infrainguinal Peripheral ArTeries)

The United States Patent & Trademark Office (USPTO) issued two new patents today for the GPX Embolic Particle device, a biocompatible catheter delivered embolic technology designed for use in arteries and veins.

Jim Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO), and Denise McCarty, Executive Director of the Oregon Bioscience Association, issued statements after Governor Kate Brown (D-OR) signed into law HB 4005.

NantKwest announced that the company will be presenting and conducting one-on-one meetings at a number of investment and healthcare conferences in the month of March and April 2018.

Regeneron Pharmaceuticals, Inc. and Society for Science & the Public today announced that Benjamin “Benjy” Firester, 18, of New York City, won the top award in the Regeneron Science Talent Search 2018.

On Friday March 9, 2018, a press conference was held where Dr. Douglas Kalman PhD, RD, FACN, FISSN and the UFC’s Featherweight fighter Chas Skelly met the press to reveal the results of a new study that demonstrated that Axiom Foods’ Oryzatein® brown rice protein equals animal-based whey protein for building and maintaining muscle.

Natera, Inc. reported financial results for the fourth quarter and fiscal year ended December 31, 2017 and provided an update on recent business progress.